DWTX/ 12/22/2025 · 11:53 AM Dogwood Therapeutics: Red Flags in Latest Trial Update Dogwood Therapeutics' (DWTX) Phase 2b trial results reveal gaps, delayed timelines, and questions about their chemotherapy pain treatment Halneuron.
